32 filings
8-K
Translate Bio, Inc.
14 Sep 21
Completion of Acquisition or Disposition of Assets
10:12am
8-K
Translate Bio, Inc.
3 Aug 21
Tender and Support Agreement
8:03am
8-K
Translate Bio, Inc.
16 Jun 21
Departure of Directors or Certain Officers
4:48pm
8-K
Translate Bio, Inc.
20 Apr 21
Departure of Directors or Certain Officers
4:31pm
8-K
Translate Bio, Inc.
23 Mar 21
Departure of Directors or Certain Officers
4:32pm
8-K
pn4ryl
25 Feb 21
Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
4:06pm
8-K
28w 1tcgunsg16
28 Dec 20
Departure of Directors or Certain Officers
4:26pm
8-K
9pjbcw
22 Dec 20
Departure of Directors or Certain Officers
4:30pm
8-K
n5or7ab rxngp0b7duj
25 Aug 20
Regulation FD Disclosure
10:15am
8-K
2ezwfwzgpav
20 Jul 20
Other Events
4:17pm
8-K
yx2yxm32i0awc 90
26 Jun 20
Translate Bio Announces Pricing of Public Offering of Common Stock
4:09pm
8-K
3mb9iw2qttda
23 Jun 20
Sanofi and Translate Bio Expand Collaboration to Develop mRNA Vaccines across
6:06am
8-K
4l8438woakszhpym
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
k9w dbu724jc
7 Apr 20
Other Events
5:27pm
8-K
xorwqm hwqk
27 Mar 20
Sanofi Pasteur and Translate Bio to collaborate to develop a novel mRNA vaccine candidate againstCOVID-19
6:09am
8-K
d09q9 prc1w9od
26 Mar 20
Other Events
4:45pm
8-K
w79f7ww
13 Jan 20
Results of Operations and Financial Condition
6:50am
8-K
auuyvq29n k1
12 Dec 19
Translate Bio Announces Executive Leadership Appointments
4:23pm
8-K/A
852kk3vd
25 Oct 19
Material Impairments
4:32pm
8-K
ktw0syim 27kq0d3
18 Sep 19
Translate Bio Announces Pricing of Public Offering of Common Stock
4:16pm